List of Angiotensin-receptor blocker (ARB) trials for COVID-19:
- Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 (COVIDMED)
- Study of Open Label Losartan in COVID-19
- Losartan for Patients With COVID-19 Requiring Hospitalization
- Losartan for Patients With COVID-19 Not Requiring Hospitalization
- Coronavirus Response - Active Support for Hospitalised Covid-19 Patients (CRASH-19)
- Telmisartan for Treatment of COVID-19 Patients
- Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19) (COVERAGE)
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease (CLARITY)
- Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia
- Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection (TITAN)
- Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) (ACOVACT)
- Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
